• LATEST NEWS: The only conference in Australia offering multidisciplinary insights into the complex nature of pain management from a variety of medical, nursing and allied health perspectives.
  • bioCSL

    bioCSL
  • Mundipharma

    Mundipharma
  • Pfizer

    Pfizer
  • Indivior

    Indivior
  • Reckitt Benckiser - Health, Home and Hygiene

    Reckitt Benckiser - Health, Home and Hygiene
  • bioCSL

    bioCSL
  • Mundipharma

    Mundipharma
  • bioCSL

    bioCSL
  • Indivior

    Indivior
  • Mundipharma

    Mundipharma
  • Pfizer

    Pfizer
  • Reckitt Benckiser - Health, Home and Hygiene

    Reckitt Benckiser - Health, Home and Hygiene

2015 Australian Pain Society
35th Annual Scientific Meeting

2015 Australian Pain Society
35th Annual Scientific Meeting

APS BLOG LATEST POSTS

    An error occurred while trying to process .
    Please contact the webmaster.

Pharmacological Management in Pain

Date: Sunday 15 March 2015

Time: 8.30 am - 1.00 pm

Cost: $110 (Early Bird), $135 (Standard)

To view the current program please click here

To view the workshop flyer please click here

Proudly Sponsored by:

The pharmacological management of pain is increasingly becoming a worldwide challenge. International experts are involved in intensive research to be able to cope with the various concerns with regard to treatment. The aim of the Pharmacological Management in Pain half-day workshop is to make a significant contribution to the optimisation of pain treatment by bringing experts together to discuss the latest scientific findings within the pain management clinical pharmacology field. Scientific, regulatory or strategy issues that are highly relevant to the optimisation of acute and chronic pain treatment will also be exchanged and discussed. This workshop will consist of invited lectures, abstract presentations and roundtable discussions. Time will be allocated to questions, answers and discussion in order to set up an intimate interactive workshop. 


Topics will include:

  • Pharmacokinetics and pharmacodynamics of new pain medications, including Tapantadol 
  •  Pharmacokinetics and pharmacodynamics of approved opioids drugs 
  • Pharmacokinetic – pharmacodynamic modeling 
  • Drug-drug and drug-disease interactions 
  • New chronic pain drug development tools 
  • Clinical case studies in palliative care and chronic non-cancer pain 

The target audience for this workshop consists of clinical pharmacologists, pharmacists, industry researchers, pain specialists, paediatricians, clinical nurse consultants, government representatives and other experts with an interest in clinical pharmacology.

Speakers:

 

A/Professor Arun Aggarwal MBBS, FRACP, FAFRM (RACP), FAFPM (ANZCA), PhD is a Clinical Associate Professor through Sydney Medical School, The University of Sydney. He is a Visiting Neurologist at Concord hospital, a Chronic Pain Specialist at the RPAH Pain Clinic and a Rehabilitation Specialist at Balmain Hospital. 

Dr Ghauri Aggarwal has been the Head of the Palliative Care Department at Concord Hospital since 1996. Her practice includes hospital consultancy, ambulatory and inpatient care in palliative medicine within the district wide Sydney Palliative Care Service, SLHD. She has been involved in the development of the Royal Australasian College of Physicians Chapter of Palliative Medicine and is the chair of the Executive of the Sydney Institute of Palliative Medicine. Her interests include interface between oncology and palliative medicine, undergraduate and postgraduate education in palliative care, communication skills and ethics and end of life decision making. She has co-authored a few publications on hospital based palliative medicine, pain management and is currently involved in research into end of life care. Currently she is involved in teaching and development of Palliative Care in the Asia-Pacific region.

Dr Charles Brooker is an anaesthetist and has been practicing pain medicine for fifteen years. He is involved in all aspects of acute and chronic pain medicine and related clinical research. Currently he is PI on a sponsored study of topical oxycodone in PHN and a co-investigator on the Medtronic SubQ stim study and further studies into spinal cord stimulation and painful diabetic neuropathy. He has been a co-investigator in research into placebo mechanisms and novel intrathecal agents for pain.  He is currently head of department of pain medicine at Royal North Shore Hospital.

Mr Tony Hall has been a practicing Clinical Pharmacist for more than 30 years working initially in the UK before moving to Australia in 1999. He has focussed his practice on the management of symptoms in Palliative Care but more recently in the pharmacotherapy of Persistent Pain. He is currently studying for a PhD with Griffith University focussing on clinical aspects of the use of the ‘pentinoid’ antiepileptic analgesics; gabapentin and pregabalin.

Tim Ho is currently a Pain and Rehabilitation Medicine Physician at Sydney Pain Management Centre (SPMC) located Sydney Adventis hospital and Parramatta.  He is an Independent Medical Examiner for Independent Medical Opinion/Vocational Capacity Centre and ASSESS medical. He is a Lecturer for Sydney University and undertake collaborative research with University of Western Sydney.  Tim has received training to date in major tertiary pain and rehabilitation centres include Royal Price Alfred Hospital (RPA Sydney), Concord Hospital, Westmead Hospital and St. Vincent’s Hospital Sydney.

Associate Professor Mark Hutchinson is an Australian Research Council Research Fellow in the School of Medical Sciences at the University of Adelaide. Having graduated with a PhD (Medicine) in Pharmacology from the University of Adelaide, Mark joined Prof Linda Watkins lab at the University of Colorado at Boulder. It was here Mark extended his training in Neuroscience and pioneered work establishing a role for immune signals within the brain as pivotal to persistent pain pathologies, altered opioid analgesic responses and activation of reward pathways. Mark's team are funded through the NHMRC, ARC, National Institutes of Health, USA Department of Defence and National Breast Cancer Foundation.

Professor Lona Louring Christrup is currently employed at Department of Drug Design and Pharmacology, University of Copenhagen as a professor in Clinical Pharmacy. Professor Christrup obtained a master degree in Pharmaceutics, at the University of Copenhagen in 1983, and was thereafter enrolled as PhD student. After having finished her Ph.D. project in biopharmaceutics in 1986, Professor Christrup entered a tenure track . During her career sher has profited greatly from joining other research settings. Thus, she has been on sabbaticals at The Department of Pharmaceutical Sciences at The University of Nottingham in UK in 1988, and from 1994 to 1997 intermittently at The Department of Clinical and Experimental Pharmacology, University of Adelaide in Australia. From the early stages of her PhD. project, most of the research has been carried out in close collaboration with clinicians at hospitals. Professor Christrup's research focus has been on opioids: dose response relationships, influence on administration route and dosage form upon pharmacokinetics, and pharmacodynamics (analgesia and side effects), their similarities and differences when used in pain treatment. 


Professor Maree Smith
 is Executive Director of the Centre for Integrated Preclinical Drug Development at The University of Queensland (UQ) and she has considerable expertise in pain, pain medicines and in new drug development. The CIPDD has a portfolio of preclinical pain models that is unique in Australia and rare internationally. The CIPDD is GLP-accredited and provides R&D drug development capabilities under the brand name, TetraQ, to academic and industry organisations in the biopharmaceutical sector.

 

Chairs:

Olly Zekry obtained her Bachelor of Pharmacy and Post Graduate Diploma in Hospital Pharmacy from University of Tasmania. She has completed her Masters in Pain Management from Sydney University and  is now the unit coordinator for the pharmacology unit of the course with the Pain Management and Research Centre, Faculty of Medicine, Sydney Medical School at the Royal North Shore Hospital. 
She has had a strong interest in education and teaching for many years. 
She has had international publications including Conversion of Gabapentin to Pregabalin with Professor Stephan Schug.
She also works  as a Clinical Pharmacist in the Pharmacy Department at the Royal Prince Alfred Hospital. She won the QUM (Quality Use Of Medicine) Award for Pain Management for Pharmacists across Australia in 2014.
She does Home Medications Reviews mainly in the rural areas of NSW.
She was heavily involved with the ketamine project at the Royal Prince Alfred Hospital Pain Management Centre  and has presented posters  and  oral presentation overseas at major international pain conferences in Milan, Toronto and Rotorua for the Pain Management Centre.  Olly conceived the idea of running the Pharmacology workshop at this year's APS Scientific Meeting in Brisbane and was responsible for generating the topics to be covered by our esteemed speakers.



Dr David Roselt is a Principal and Partner at Aberdovy Clinic, Bundaberg. He is a Fellow of the Australian Faculty of Musculoskeletal Medicine, Fellow of the RACGP, and Member of the RACGP Musculoskeletal Special Interest Group. Dr Roselt is a Senior Lecturer in the Department of Medicine at the University of Queensland, has a Post Graduate Diploma in Musculoskeletal Medicine from Otago University, and is completing a Masters Degree in Pain Management at Sydney University. He is a former editor of Australasian Musculoskeletal Medicine, and has authored or co-authored papers on somatic referred pain, paraspinal nerve injection and post herpetic neuralgia.  His special interests include the non-surgical management of spinal pain, therapeutic injection techniques for pain management including caudal epidural injection and paraspinal nerve injection, and neuropathic pain. 

Sandra Tutt has over 37 years working as a registered nurse working in various specialty fields. In the last 20 years she has been working in Pain Management and has had the opportunity to work in multidisciplinary pain teams at Royal North Shore, Liverpool, Royal Prince Alfred and now Concord Hospital.  As a clinical nurse consultant in pain management since 2000, Sandra has extensive experience in the planning and management of patients with Acute and Chronic (Persistent) pain.   This experience includes postoperative ward patients, outpatient clinics, and cognitive programmes.  Sandra is very active in the Nurses Pain Interest Group and is currently the Chairperson.  She is also a regular guest lecturer in colleges and universities and has on several occasions been asked to speak interstate and to nurses in China and Thailand.


For further information please contact the APS Secretariat: DC Conferences Pty Ltd
Suite 103, Level 1, 3-5 West Street, North Sydney NSW 2060, Australia | PO Box 637, North Sydney 2059
P 612 9954 4400 | F 612 9954 0666 | E aps2015@dcconferences.com.au